Barbara Härtl
- Genetics top 10%
- Virus-based gene therapy research 10
- Bacterial Genetics and Biotechnology 2
-
- Cancer Research and Treatments 6
-
- Biopolymer Synthesis and Applications 1
- Ubiquitin and proteasome pathways 1
-
- CAR-T cell therapy research 3
- Cancer-related Molecular Pathways 2
-
- Bacteriophages and microbial interactions 3
Barbara Härtl
12 papers receiving 377 citations
Peers
Comparison fields: 5 of 44
- Genetics 285
- Biotechnology 41
- Molecular Biology 269
- Oncology 101
- Immunology 57
Countries citing papers authored by Barbara Härtl
This map shows the geographic impact of Barbara Härtl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Härtl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Härtl more than expected).
Fields of papers citing papers by Barbara Härtl
This network shows the impact of papers produced by Barbara Härtl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Härtl. The network helps show where Barbara Härtl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barbara Härtl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2014 | 10 | |
| 3 | 2014 | 7 | |
| 4 | 2014 | 15 | |
| 5 | 2013 | 41 | |
| 6 | 2012 | 21 | |
| 7 | 2011 | 14 | |
| 8 | 2008 | 31 | |
| 9 | 2007 | 83 | |
| 10 | 2004 | 39 | |
| 11 | 2001 | 3 | |
| 12 | 2001 | 110 |
About Barbara Härtl
Barbara Härtl is a scholar working on Biotechnology, Genetics and Oncology, having authored 12 papers that have together received 378 indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), Cancer Research and Treatments (6 papers), Bacteriophages and microbial interactions (3 papers), CAR-T cell therapy research (3 papers), Bacterial Genetics and Biotechnology (2 papers), Cancer-related Molecular Pathways (2 papers), Biopolymer Synthesis and Applications (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Genetics (285 citations), Biotechnology (41 citations) and Molecular Biology (269 citations). Barbara Härtl has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Thomas Dobner, Georg Homuth, Wolfgang Wehrl, Wolfgang Schumann, Thomas Wiegert, Joachim Hauber, Paola Blanchette, Peter Groitl, Elisabeth Kremmer and Aladar A. Szalay. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.